- ►annals.org RA Brodsky, M Petri, BD Smith, EJ Seifter, JL … - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Immunoablative high-dose cyclophosphamide without stem-cell ... Cited by 192 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org [PDF] HH Euler, AM Marmont, A Bacigalupo, S … - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 199 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org - Free from Publisher RK Burt, AE Traynor, R Pope, J Schroeder, B … - Blood, 1998 - bloodjournal.hematologylibrary.org Multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis are
immune-mediated diseases that are responsive to suppression or modulation of the
immune system. For patients with severe disease, immunosuppression may be ... Cited by 187 - Related articles - BL Direct - All 4 versions
- ►thelancet.com AE Traynor, J Schroeder, RM Rosa, D Cheng, J … - The Lancet, 2000 - Elsevier From 1996, we selected patients with persistent SLE despite use of
cyclophosphamide. Patients underwent dose-intense immune suppression and
autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ... Cited by 200 - Related articles - BL Direct - All 7 versions
- ►hematologylibrary.org [PDF] RA Brodsky, LL Sensenbrenner, RJ Jones - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 119 - Related articles - BL Direct - All 7 versions
M Musso, F Porretto, A Crescimanno, F Bondi, … - Lupus, 1998 - lup.sagepub.com Immunoablation followed by allogeneic stem cell (SC) transplantation has been
shown to be capable of curing a large spectrum of experimental autoimmune
disorders, hereditary and/or induced. Superimposable results, albeit with ... Cited by 63 - Related articles - BL Direct - All 3 versions
A Tyndall, A Fassas, J Passweg, C Ruiz de … - Bone marrow transplantation(Basingstoke), 1999 - cat.inist.fr This ongoing multicentre prospective phase I/II trial enrolled 74 consecutive
patients from 22 centres worldwide with severe autoimmune disease, 35 with
rheumatological disorders, 31 with neurological, five with haematological ... Cited by 124 - Related articles - BL Direct - All 2 versions
RK Burt, C Georganas, J Schroeder, A Traynor … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 73 - Related articles - BL Direct - All 3 versions
AM Marmont, MT Van Lint, F Gualandi, A … - Lupus, 1997 - lup.sagepub.com Page 1. http://lup.sagepub.com Lupus DOI: 10.1177/096120339700600613 1997; 6; 545
Lupus AM Marmont, MT van Lint, F. Gualandi and A. Bacigalupo duration ... Cited by 125 - Related articles - BL Direct - All 3 versions
M Petri, RJ Jones, RA Brodsky - Arthritis and rheumatism, 2003 - assets0.pubget.com Objective. High-dose chemotherapy followed by hematopoietic stem cell
transplantation is increasingly being studied as a treatment for severe
autoimmune disorders, such as systemic lupus erythematosus (SLE). High-dose ... Cited by 105 - Related articles - View as HTML - BL Direct - All 5 versions
